GM-CSF and IL-2 combination as adjuvant therapy in cutaneous melanoma: early results of a phase II clinical trial.

Oncology (Williston Park, N.Y.)

Volumn 19, Issue 4 Suppl 2, 2005, Pages 15-18

  Elias, E George ^a   Zapas, John L ^a   Beam, Sandra L ^a   Brown, Sally D ^a  

^a Franklin Square Hospital Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 2; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MALE; MELANOMA; METHODOLOGY; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; SKIN TUMOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 23444460740     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)